Bionano Genomics (BNGO) Gross Profit (2017 - 2026)

Bionano Genomics has disclosed Gross Profit across 10 years of filings, most recently posting $3.3 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $3.3 million, up 10.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (up 165.55% YoY), and the FY2025 annual result was $13.2 million, up 3369.74% from the prior year.
• Gross Profit came in at $3.3 million for Q1 2026 at Bionano Genomics, down from $3.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2024 to a low of -$8.4 million in Q3 2024.
• The 5-year median for Gross Profit is $2.6 million (2024), against an average of $2.2 million.
• Across the five-year window, Gross Profit jumped 655.23% in 2022 and plunged 407.24% in 2024, its largest moves.
• Bionano Genomics' Gross Profit stood at $1.8 million in 2022, then jumped by 35.07% to $2.4 million in 2023, then soared by 228.38% to $8.0 million in 2024, then slumped by 57.54% to $3.4 million in 2025, then declined by 4.32% to $3.3 million in 2026.
• The last three Gross Profit figures came in at $3.3 million (Q1 2026), $3.4 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.